Acetate abates adipose-ovarian endocrinometabolic disturbance in experimentally induced polycystic ovarian syndrome
Steroids · 2025-02 · 214 · 109554
DOI: 10.1016/j.steroids.2024.109554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Steroids, 2025-02. Verfasst von Kehinde S Olaniyi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardio/Endo-metabolic and Microbiome Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-E…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Rats, Wistar, Ovary, Letrozole. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Besides ovarian dysfunction and infertility, individuals with polycystic ovarian syndrome (PCOS) also present a number of systemic disturbances including functional derangements in the adipose tissue which possibly aggravates the endocrinometabolic abnormality in PCOS. Epigenetic changes have been implicated in metabolic-related disorders including PCOS. However, its pathogenic involvement in adipose-ovarian dysfunction is unclear. Therefore, the present research was designed to investigate the impact of epigenetic regulator, particularly short chain fatty acids (SCFAs) on adipose-ovarian dysfunction in PCOS rat model. MATERIALS AND METHODS: Eight-weeks-old female Wistar rats were allotted into four groups of n = 5, namely control, sodium acetate (SACT), letrozole (LETZ), and LETZ + SACT. Letrozole (1 mg/kg; p.o.) was administered daily for 21 days to induce PCOS. Thereafter, the animals were treated daily with SACT (200 mg/kg; p.o.) for 6 weeks. RESULTS: Letrozole-induced PCOS rats were presented with androgen excess, insulin resistance/hyperinsulinemia, ovarian cystic follicles, increased levels of anti-Mullerian hormone, leptin, with a corresponding decrease in 17-β estradiol, and adiponectin. In addition, the LETZ group also showed dyslipidemia, decreased levels of adipose/ovarian sirtuin-1, adipose triglyceride, increased lipase activity as well as ovarian triglyceride, with corresponding increase in adipose/ovarian lipid peroxidation, caspase-6, TGF-β1, inflammatory response (TNF-α, NF-κB and MIF) and decreased GSH. Adipose/ovarian mitofusin 2 depletion was observed in LETZ group and this was accompanied by elevated HDAC2. Nevertheless, administration of acetate reversed these perturbations. CONCLUSION: Overall, the present results suggest that acetate ameliorates adipose-ovarian metabolic and endocrine disruptions that accompany PCOS, and these beneficial effects of acetate are associated with reduction of HDAC2 levels and elevation of mitofusin 2/sirtuin-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardio/Endo-metabolic and Microbiome Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria. Electronic address: olaniyisk@abuad.edu.ng.
- Cardio/Endo-metabolic and Microbiome Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360101, Nigeria.
- Laboratory of Endocrinology, Department of Bioscience, Barkatullah University, Bhopal, Madhya Pradesh 462026, India.
Zitieren
APA
Olaniyi, K. S., Areloegbe, S. E., & Ul Haq Shah, M. Z. (2025). Acetate abates adipose-ovarian endocrinometabolic disturbance in experimentally induced polycystic ovarian syndrome. Steroids, 214, 109554. https://doi.org/10.1016/j.steroids.2024.109554
Vancouver
Olaniyi KS, Areloegbe SE, Ul Haq Shah MZ. Acetate abates adipose-ovarian endocrinometabolic disturbance in experimentally induced polycystic ovarian syndrome. Steroids. 2025;214:109554. doi:10.1016/j.steroids.2024.109554
BibTeX
@article{Olaniyi2025,
author = {Olaniyi, Kehinde S and Areloegbe, Stephanie E and Ul Haq Shah, Mohd Z},
title = {Acetate abates adipose-ovarian endocrinometabolic disturbance in experimentally induced polycystic ovarian syndrome},
journal = {Steroids},
year = {2025},
volume = {214},
pages = {109554},
doi = {10.1016/j.steroids.2024.109554}
}
EUVIMED